IP Library › Granted Patent US 7,785,617
Granted Patent B2
US 7,785,617 · App. 10/481,923 · Granted Aug 31, 2010

Porous matrix comprising cross-linked particles

Assignee: The University of Nottingham
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,785,617
App. No.
10/481,923
Granted
Aug 31, 2010
Kind
B2
Abstract

An open porous matrix of particulate material for in vivo use in or on a target tissue in medicine, the matrix comprising particles cross-linked with one another so as to define pores there between and uses therefor are described.

Claims (13)

1. An open porous matrix of particulate material for in vivo use in or on a target tissue in medicine, the matrix comprising particles cross-linked with one another so as to define pores there between, each particle being cross-linked to one or more particles within the matrix, wherein the particles are formed from silk, elastin, chitin, chitosan, poly (α-hydroxyacids), poly(anhydrides), poly(orthoesters) or mixtures thereof.

2. A matrix according to claim 1 , wherein the particles are between 1 nm and 1 mm.

3. A matrix according to claim 1 , wherein the particles are between 100 nm and 500 μm.

4. A matrix according to claim 1 , in which the poly (α-hydroxyacid) is selected from the group consisting of polyhydroxybutyric acid, lactic acid, polylactic acid, glycolic acid, polyglycolic acid, and s-caproic acid.

5. A matrix according to claim 1 , in which the particle is hollow or absorbent.

6. A matrix according to claim 1 , in which the matrix contains a substance to be released at or on a target site.

7. A matrix according to claim 6 , in which some particles contain a bolus or boli of substance embedded with the particle for release at the target site.

8. A matrix according to claim 6 , in which the substance is a drug, hormone, enzyme, nutrient, or other therapeutic agent, or mixtures thereof.

9. A matrix according to claim 6 , in which the substance is selected from the group consisting of epidermal growth factor (EGF), nerve growth factor, insulin-like growth factor (IFG), basic fibroblast growth factor (bFGF), platelet derived growth factor (PDGF), transforming growth factor-P, cytokines, oestrogen, testosterone, kinases, chemokinases, sugars, amino acids, dopamine, amine-rich oligopeptides, amines, tamoxifen, cis-platin, and toxoids.

10. A matrix according to claim 1 , in which the particles are biodegradable.

11. A matrix according to claim 1 , in which the particles are biocompatible.

12. A matrix according to claim 1 , in which the particles are cross-linked by a cross-linking agent which is a biologically active ligand.

13. A fluid composition comprising particulate material and a cross-linking agent whereby, in use, the particles cross-link to form a cross-linked matrix comprising particles cross-linked with one another so as to define pores there between on introduction to the cross-linking agent in or on a target tissue.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2004
From: SHAKESHEFF, KEVIN M.; SALEM, ALIASGER KARIMJEE
To: UNIVERSITY OF NOTTINGHAM, THE
Reel/Frame 015613/0124 →
Priority Claims (1)
GB 0115320.4 · Jun 22, 2001 · national
Continuity (1)
Related Publication 20040241203A1 · Dec 2, 2004